WIN Consortium Appoints Winston and Strawn LLP as Official Legal Counsel

PARIS. - Tuesday, February 25th 2014 [ME NewsWire]

(BUSINESS WIRE) The Worldwide Innovative Network (WIN) Consortium in personalized cancer medicine, www.winconsortium.org is proud to announce Winston and Strawn LLP (www.winston.com) has been appointed as their official legal advisor. WIN is a global network of leading academic, industry, payors and patient advocacy organizations working to make precision cancer care a reality for patients worldwide. WIN’s goal is to significantly improve survival and quality of life of cancer patients in the next three years. Today WIN counts 32 members in 5 continents :

1. 19 academic cancer centers across the globe, representing a diversity of populations of which: MDAnderson Cancer Center, Houston (MDACC); University of California San Diego (UCSD); New York University Langone Medical Cancer Centre (NYUCC), USA; McGill University Segal Cancer Center, Canada; Barretos, Brazil; Institut Gustave Roussy, France; DKFZ German Cancer Research Center (DKFZ), Germany; Instituto Nazionale dei Tumori (INT) & Istituto Europeo di Oncologia, (IEO) Italy; Vall d’Hebron (VHIO) Spain; Hadassah University, Chaim Sheba Medical Center & Ben-Gurion University of the Negev, Israel; University of Medicine and Pharmacy (UMF) and Oncology Institute Ion Chiricuta (IOCN), Romania; King Hussein Cancer Center (KHCC), Jordan; Fudan University Shanghai Cancer Center, China; Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) India; National Cancer Center (NCC) Singapore and Semmelweis University, Hungary. 2. Pharmaceutical companies and technology: Pfizer Inc., AstraZeneca & Millennium Takeda, Foundation Medicine, Oracle, GE Healthcare, Agilent and Life Technologies 3. Healthplan: Blue Cross Blue Shield Association, USA 4. Patient advocacy: National Breast Cancer Foundation, USA 5. Non-profit research organization: Sage Bionetworks, EORTC

Dr. Vladimir Lazar, Founder and Chief Operating Officer of WIN Consortium stated: ‘’WIN was formed on the premise that WIN members can accomplish together what no single Institution or group of patients can do alone. To achieve this strategic goal, Winston & Strawn LLP Paris partner Jérôme Herbet and associate Rim Khirddine provided invaluable assistance in setting up a consortium agreement ratified by the 32 member institutions worldwide”.

“We are thrilled that all members adhered to the consortium agreement” stated Gilles Bigot, Managing Partner of the Paris office of Winston and Strawn LLP. ‘’The agreement should help the WIN Consortium achieve its ambitious projects. We are proud to become the official legal advisors of WIN, a unique model of worldwide cooperation between all stakeholders of cancer care’’ added Gilles Bigot.

For further information about WIN Consortium and Winston and Strawn LLP, please visit www.winconsortium.org and www.winston.com

Contacts

WIN Consortium

Catherine Bresson, +33(0) 142114020

Director, Operations

Catherine.bresson@winconsortium.org









Permalink: http://www.me-newswire.net/news/10124/en